Growth Hormone Market Size & Share - Analysis Report, 2032

Growth Hormone Market - By Product (Powder, Solvent), Application (Growth Hormone Deficiency, Idiopathic Short Stature, Turner Syndrome, Small for Gestational Age, Prader-Willi Syndrome), Distribution Channel (Hospital, Retail), & Global Forecast, 2023 - 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Forecast parameters

1.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data Sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Global growth hormones market 360&deg; synopsis, 2018 - 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Regional trends

2.1.3&nbsp;&nbsp;&nbsp; Product trends

2.1.4&nbsp;&nbsp;&nbsp; Application trends

2.1.5&nbsp;&nbsp;&nbsp; Distribution channel trends

Chapter 3&nbsp;&nbsp;&nbsp;Growth Hormone Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Increasing prevalence of growth hormone deficiency

3.2.1.2&nbsp;&nbsp;&nbsp;Growing R&amp;D activities in growth hormone industry

3.2.1.3&nbsp;&nbsp;&nbsp;Technological advancements in drug delivery systems

3.2.1.4&nbsp;&nbsp;&nbsp;Increasing applications of growth hormone therapy in pediatric patients

3.2.1.5&nbsp;&nbsp;&nbsp;Rising awareness about the synthetic growth hormone therapy in developing regions

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;High cost of synthetic growth hormone treatment

3.2.2.2&nbsp;&nbsp;&nbsp;Side effects associated with use of synthetic growth hormones

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By product

3.3.2&nbsp;&nbsp;&nbsp; By application

3.3.3&nbsp;&nbsp;&nbsp; By distribution channel

3.4&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Technology landscape

3.6&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.4&nbsp;&nbsp;&nbsp; Brand analysis

4.5&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Growth Hormone Market Size and Forecast, By Product (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by product

5.2&nbsp;&nbsp;&nbsp; Powder

5.3&nbsp;&nbsp;&nbsp; Solvent

Chapter 6&nbsp;&nbsp;&nbsp;Growth Hormone Market Size and Forecast, By Application (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by application

6.2&nbsp;&nbsp;&nbsp; Growth hormone deficiency

6.3&nbsp;&nbsp;&nbsp; Idiopathic short stature

6.4&nbsp;&nbsp;&nbsp; Turner syndrome

6.5&nbsp;&nbsp;&nbsp; Small for gestational age

6.6&nbsp;&nbsp;&nbsp; Prader-Willi syndrome

6.7&nbsp;&nbsp;&nbsp; Other applications

Chapter 7&nbsp;&nbsp;&nbsp;Growth Hormone Market Size and Forecast, By Distribution Channel (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by distribution channel

7.2&nbsp;&nbsp;&nbsp; Hospital pharmacy

7.3&nbsp;&nbsp;&nbsp; Retail pharmacy

7.4&nbsp;&nbsp;&nbsp; Online medstores

Chapter 8&nbsp;&nbsp;&nbsp;Growth Hormone Market Size and Forecast, By Region (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by region

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; Japan

8.4.2&nbsp;&nbsp;&nbsp; China

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

8.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East &amp; Africa

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Novo Nordisk A/S

9.2&nbsp;&nbsp;&nbsp; Pfizer Inc.

9.3&nbsp;&nbsp;&nbsp; Novartis AG

9.4&nbsp;&nbsp;&nbsp; Eli Lily And Company

9.5&nbsp;&nbsp;&nbsp; Merck KGaA

9.6&nbsp;&nbsp;&nbsp; Ipsen S.A.

9.7&nbsp;&nbsp;&nbsp; Anhui Anke Biotechnology (Group) Co., Ltd

9.8&nbsp;&nbsp;&nbsp; LG Chem Ltd.

9.9&nbsp;&nbsp;&nbsp; Ferring B.V.

9.10&nbsp;&nbsp;&nbsp; Genetech Inc. (Roche Group) 
&nbsp;

Growth Hormone Market

Customize This Report

Industries

Information

Link

Global Headquarters